CWBHF logo

Charlotte's Web Holdings, Inc. (CWBHF)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Charlotte's Web Holdings, Inc. (CWBHF) with AI Score 51/100 (Hold). Charlotte's Web Holdings, Inc. focuses on producing and distributing hemp-derived cannabidiol (CBD) wellness products. Market cap: 0, Sector: Healthcare.

Last analyzed: Mar 16, 2026
Charlotte's Web Holdings, Inc. focuses on producing and distributing hemp-derived cannabidiol (CBD) wellness products. The company's diverse product range includes tinctures, gummies, capsules, and topicals marketed under brands like Charlotte's Web and CBD Medic.
51/100 AI Score

Charlotte's Web Holdings, Inc. (CWBHF) Healthcare & Pipeline Overview

CEOWilliam J. Morachnick
Employees112
HeadquartersLouisville, US
IPO Year2018

Charlotte's Web Holdings, Inc. cultivates, manufactures, and distributes hemp-derived CBD wellness products, including tinctures, gummies, and topicals, targeting both human and pet markets through retail and online channels, while navigating a complex regulatory landscape in the specialty drug sector.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 16, 2026

Investment Thesis

Charlotte's Web Holdings, Inc. operates in the evolving CBD wellness market. The company's diverse product portfolio and established brand presence are key value drivers. Growth catalysts include expanding retail partnerships and continued product innovation. However, the company faces risks related to regulatory uncertainty and competition within the CBD industry. With a market capitalization of $0.10 billion and a negative P/E ratio of -4.57, the company's profitability remains a concern. Investors should monitor the company's ability to achieve profitability and navigate the regulatory landscape to capitalize on the growing demand for CBD products. The company's gross margin of 44.3% indicates potential for improved profitability with scale.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $0.10 billion reflects the company's current valuation in the competitive CBD market.
  • Gross margin of 44.3% indicates the company's ability to generate revenue from its products after accounting for the cost of goods sold.
  • Negative P/E ratio of -4.57 suggests the company is currently unprofitable, requiring further analysis of its financial performance.
  • The company's beta of 2.41 indicates higher volatility compared to the overall market, suggesting a riskier investment.
  • The company's collaboration with the University at Buffalo and McLean Hospital highlights its commitment to research and development in the CBD space.

Competitors & Peers

Strengths

  • Established brand recognition
  • Diverse product portfolio
  • Strong distribution network
  • Commitment to research and development

Weaknesses

  • Negative profitability
  • High beta indicating volatility
  • Dependence on evolving regulatory landscape
  • Intense competition in the CBD market

Catalysts

  • Ongoing: Expansion of retail partnerships to increase product distribution and market reach.
  • Ongoing: Product innovation and diversification to cater to evolving consumer preferences and health needs.
  • Upcoming: Potential regulatory changes in the CBD industry that could impact market access and product labeling.
  • Ongoing: Research and development efforts to validate the efficacy and safety of CBD products.
  • Ongoing: International expansion initiatives to tap into new markets and revenue streams.

Risks

  • Ongoing: Regulatory uncertainty and evolving legal landscape surrounding CBD products.
  • Ongoing: Intense competition from other CBD manufacturers and distributors.
  • Potential: Fluctuations in hemp prices and supply chain disruptions.
  • Potential: Changing consumer preferences and market trends.
  • Potential: Negative publicity or adverse events related to CBD products.

Growth Opportunities

  • Expansion of Retail Partnerships: Charlotte's Web can drive growth by expanding its distribution network through partnerships with major retailers. The increasing acceptance of CBD products in mainstream retail channels presents a significant opportunity to reach a broader customer base. Securing shelf space in national chains and regional retailers can significantly boost sales volume and brand visibility. The timeline for realizing this growth opportunity is immediate and ongoing, as the company continues to pursue and cultivate retail partnerships. This strategy leverages the growing market demand for accessible CBD products.
  • Product Innovation and Diversification: Investing in research and development to create new and innovative CBD products can drive growth. Developing targeted formulations for specific health conditions, such as sleep, stress, and pain management, can attract new customers and increase market share. Expanding the product line to include novel delivery methods, such as transdermal patches or inhalers, can also differentiate Charlotte's Web from competitors. The timeline for this growth opportunity is medium-term, requiring ongoing investment in R&D and clinical trials. The potential market size for targeted CBD formulations is substantial, driven by the increasing demand for personalized wellness solutions.
  • Strategic Acquisitions and Partnerships: Acquiring complementary businesses or forming strategic partnerships can accelerate growth and expand market reach. Acquiring smaller CBD brands with unique product offerings or established customer bases can provide access to new markets and distribution channels. Partnering with pharmaceutical companies or healthcare providers can facilitate the development and commercialization of cannabinoid-based therapies. The timeline for this growth opportunity is medium to long-term, requiring careful evaluation of potential targets and partners. The potential market size for cannabinoid-based therapies is significant, driven by the increasing interest in natural alternatives to traditional pharmaceuticals.
  • International Expansion: Expanding into international markets can drive growth by tapping into new customer bases and revenue streams. The global CBD market is growing rapidly, with significant opportunities in Europe, Asia, and Latin America. Adapting product formulations and marketing strategies to meet local regulations and consumer preferences is crucial for success. The timeline for this growth opportunity is long-term, requiring careful planning and execution. The potential market size for CBD products in international markets is substantial, driven by the increasing global awareness of CBD's potential health benefits.
  • Direct-to-Consumer (DTC) Channel Optimization: Enhancing the company's online presence and DTC capabilities can drive growth by increasing customer engagement and sales. Investing in website optimization, digital marketing, and customer relationship management (CRM) can improve the customer experience and drive conversions. Offering personalized product recommendations, subscription services, and loyalty programs can increase customer retention and lifetime value. The timeline for this growth opportunity is immediate and ongoing, as the company continuously refines its DTC strategy. The potential market size for online CBD sales is significant, driven by the increasing trend of online shopping and the convenience of DTC channels.

Opportunities

  • Expansion of retail partnerships
  • Product innovation and diversification
  • Strategic acquisitions and partnerships
  • International expansion

Threats

  • Regulatory uncertainty
  • Increased competition
  • Fluctuations in hemp prices
  • Changing consumer preferences

Competitive Advantages

  • Established brand recognition and reputation in the CBD market.
  • Proprietary hemp genetics and cultivation practices.
  • Diverse product portfolio catering to various customer needs.
  • Strong distribution network through retail, online, and healthcare channels.

About CWBHF

Founded in 2013 and headquartered in Denver, Colorado, Charlotte's Web Holdings, Inc. emerged as a prominent player in the burgeoning hemp-derived CBD market. Originally known as Stanley Brothers Holdings Inc., the company rebranded in 2018 to Charlotte's Web Holdings, Inc. The company's origins are rooted in providing CBD products to individuals seeking natural wellness solutions. Charlotte's Web cultivates hemp and manufactures a range of CBD products, including hemp extract oil tinctures, gummies, capsules, and topical creams and lotions. These products are marketed under the Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp brands. The company's products contain phytocannabinoids, including CBD, cannabichromene, cannabigerol, and cannabinol, along with terpenes and flavonoids. Charlotte's Web distributes its products through retail outlets, healthcare practitioners, and its online platform. The company also engages in research and development through its CW Labs division, collaborating with institutions like the University at Buffalo and McLean Hospital to advance hemp cannabinoid science.

What They Do

  • Cultivates hemp plants for CBD extraction.
  • Manufactures hemp-derived CBD wellness products.
  • Produces CBD oil tinctures, gummies, capsules, and topicals.
  • Markets products under the Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp brands.
  • Distributes products through retail outlets, healthcare practitioners, and online.
  • Conducts research and development to advance hemp cannabinoid science.
  • Collaborates with universities and hospitals on research programs.

Business Model

  • Cultivates hemp and extracts CBD.
  • Manufactures and sells CBD products through various channels.
  • Generates revenue through retail sales, online sales, and partnerships.
  • Invests in research and development to innovate and improve products.

Industry Context

Charlotte's Web Holdings, Inc. operates within the rapidly growing CBD market, driven by increasing consumer awareness and acceptance of CBD products for wellness purposes. The industry is characterized by intense competition, evolving regulations, and varying product quality standards. Charlotte's Web differentiates itself through its established brand, diverse product portfolio, and commitment to research and development. The company competes with other CBD manufacturers and distributors, as well as pharmaceutical companies exploring cannabinoid-based therapies. Navigating the regulatory landscape and ensuring product quality are critical for success in this dynamic market.

Key Customers

  • Individuals seeking natural wellness solutions.
  • Retail consumers purchasing CBD products online and in stores.
  • Healthcare practitioners recommending CBD products to patients.
  • Pet owners seeking CBD products for their pets.
AI Confidence: 71% Updated: Mar 16, 2026

Financials

Chart & Info

Charlotte's Web Holdings, Inc. (CWBHF) stock price: Price data unavailable

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CWBHF.

Price Targets

Wall Street price target analysis for CWBHF.

MoonshotScore

51/100

What does this score mean?

The MoonshotScore rates CWBHF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: William J. Morachnick

CEO

William J. Morachnick serves as the CEO of Charlotte's Web Holdings, Inc. His background includes extensive experience in consumer packaged goods and retail industries. Prior to joining Charlotte's Web, he held leadership positions at various companies, focusing on strategic planning, operations, and business development. His expertise spans across multiple functional areas, including sales, marketing, and supply chain management. He is responsible for overseeing the company's overall strategy and operations.

Track Record: Since assuming the role of CEO, William J. Morachnick has focused on driving revenue growth, improving operational efficiency, and navigating the evolving regulatory landscape. He has overseen the expansion of the company's product portfolio and distribution network. Key milestones under his leadership include strategic partnerships and investments in research and development. He manages 112 employees.

CWBHF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Charlotte's Web Holdings, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: As an OTC stock, CWBHF may experience lower trading volumes and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult to buy or sell shares quickly and at desired prices. Investors should be aware of the potential for price volatility and illiquidity when trading CWBHF on the OTC market. The trading difficulty is high.
OTC Risk Factors:
  • Limited financial disclosure and transparency.
  • Potential for price manipulation and fraud.
  • Lower trading volumes and liquidity.
  • Higher bid-ask spreads.
  • Increased regulatory scrutiny.
Due Diligence Checklist:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Review the company's OTC Markets profile and disclosure statements.
  • Consult with a financial advisor to assess the risks and potential rewards.
  • Check for any regulatory actions or legal proceedings involving the company.
  • Understand the company's capital structure and ownership.
Legitimacy Signals:
  • Established brand presence in the CBD market.
  • Partnerships with reputable retailers and healthcare providers.
  • Commitment to research and development.
  • Active management team with relevant industry experience.
  • Publicly available information and disclosures (if any).

CWBHF Healthcare Stock FAQ

What does Charlotte's Web Holdings, Inc. do?

Charlotte's Web Holdings, Inc. is a vertically integrated company that cultivates hemp and manufactures hemp-derived CBD wellness products. The company's product portfolio includes CBD oil tinctures, gummies, capsules, and topicals marketed under the Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp brands. These products are distributed through retail outlets, healthcare practitioners, and the company's online platform. Charlotte's Web focuses on providing natural wellness solutions to consumers and pets, while also investing in research and development to advance hemp cannabinoid science.

What do analysts say about CWBHF stock?

AI analysis is currently pending for CWBHF. Generally, analysts may consider factors such as the company's revenue growth, profitability, market share, and regulatory environment when evaluating the stock. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions. Key valuation metrics to monitor include the company's price-to-sales ratio, price-to-book ratio, and enterprise value-to-EBITDA multiple. Growth considerations include the company's ability to expand its distribution network, innovate new products, and navigate the evolving regulatory landscape.

What are the main risks for CWBHF?

Charlotte's Web Holdings, Inc. faces several risks, including regulatory uncertainty, intense competition, fluctuations in hemp prices, and changing consumer preferences. The evolving legal landscape surrounding CBD products poses a significant risk, as changes in regulations could impact market access and product labeling. Increased competition from other CBD manufacturers and distributors could erode market share and pricing power. Fluctuations in hemp prices and supply chain disruptions could impact the company's cost of goods sold and profitability. Changing consumer preferences and market trends could require the company to adapt its product offerings and marketing strategies.

What are the key factors to evaluate for CWBHF?

Charlotte's Web Holdings, Inc. (CWBHF) currently holds an AI score of 51/100, indicating moderate score. Key strength: Established brand recognition. Primary risk to monitor: Ongoing: Regulatory uncertainty and evolving legal landscape surrounding CBD products.. This is not financial advice.

How frequently does CWBHF data refresh on this page?

CWBHF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CWBHF's recent stock price performance?

Recent price movement in Charlotte's Web Holdings, Inc. (CWBHF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brand recognition. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider CWBHF overvalued or undervalued right now?

Determining whether Charlotte's Web Holdings, Inc. (CWBHF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying CWBHF?

Before investing in Charlotte's Web Holdings, Inc. (CWBHF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on the most recent available information.
  • OTC market data may be limited or delayed.
Data Sources

Popular Stocks